Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to apply pericapsular nerve group (PENG) block or fascia iliaca plan block using ultrasonography to patients who will undergo hip fracture surgery, while giving sitting position before spinal anaesthesia and to reduce postoperative pain complaints. Thanks to these blocks, it is aimed to reduce pain complaints and the need for morphine-derived painkillers before and after surgery.


Clinical Trial Description

Group 1:Pericapsular nerve group (PENG) block: Using an in-plane approach with ultrasonographic imaging, the block needle reaches the fascial plane between the psoas muscle and the superior pubic ramus and local anaesthetic solution is injected. - Each patient will receive 15 ml of 0.375% bupivacaine on the side of the broken hip only one time approximately 15-20 minutes before the operation. - After the patients were sedated with intravenous 1 mg midazolam and 50 mcg fentanyl in the preoperative preparation room, 15 ml of 0.375% bupivacaine was administered to the fractured hip side under ultrasound guidance. After the block application, the patient will be taken to the operating room and standard spinale anaesthesia will be applied. - plane block applications will be performed by anaesthesiologists with at least 5 years of experience - Postoperative evaluations of patients will be performed face to face. - Plane block applications will be applied only once in the preoperative period. - Patients will be routinely administered 1 g paracetamol intravenously at 8 hour intervals in the postoperative period. 100 mg tramadol intravenously will be administered if their pain is above Numerical Rating Scale (NRS) 4 despite this. - This study was followed up in the orthopaedic service - Patients will be monitored for pain and side effects at the postanesthetic care unit , 1st hour, 2nd hour, 4th hour, 8th hour and 24th hour in the postoperative period. - The extent to which plan blocks facilitate the positioning of the patient for spinal anaesthesia in the intraoperative period will be monitored. In addition, the effects on intraoperative and postoperative opioid consumption and patient satisfaction will be observed. - Data on the observed parameters will be obtained from face-to-face questionnaires or anesthesia and nurse observation forms. Group 2: Suprainguinal fascia iliaca plane block: The needle entering in plane from the caudal end of the ultrasound probe passes through the m. sartorius and into the musculus iliacus and fascia iliaca reaches. The fascia iliaca is passed with the needle and local anaesthetic solution is injected immediately under the fascia. - Each patient will receive 15 ml of 0.375% bupivacaine on the side of the broken hip only one time approximately 15-20 minutes before the operation. - After the patients were sedated with intravenous 1 mg midazolam and 50 mcg fentanyl in the preoperative preparation room, 15 ml of 0.375% bupivacaine was administered to the fractured hip side under ultrasound guidance. After the block application, the patient will be taken to the operating room and standard spinale anaesthesia will be applied. - plane block applications will be performed by anaesthesiologists with at least 5 years of experience - Postoperative evaluations of patients will be performed face to face. - Plane block applications will be applied only once in the preoperative period. - Patients will be routinely administered 1 g paracetamol intravenously at 8 hour intervals in the postoperative period. 100 mg tramadol intravenously will be administered if their pain is above Numerical Rating Scale (NRS) 4 despite this. - This study was followed up in the orthopaedic service. - Patients will be monitored for pain and side effects at the postanesthetic care unit , 1st hour, 2nd hour, 4th hour, 8th hour and 24th hour in the postoperative period. - The extent to which plan blocks facilitate the positioning of the patient for spinal anaesthesia in the intraoperative period will be monitored. In addition, the effects on intraoperative and postoperative opioid consumption and patient satisfaction will be observed. - Data on the observed parameters will be obtained from face-to-face questionnaires or anesthesia and nurse observation forms. - Statistical methods / analysis: G-Power version 3.1.9.4 (University Kiel, Germany) program was used to calculate the sample size. The two-tailed alpha error was taken as 0.05, power as 0.80 and effect size as 0.8, and based on a previous study the allocation ratio was accepted as N2/N1:1. The minimum number of patients to be included in the study was calculated as 52. SPSS 16.0 for Windows (SPSS Inc., Chicago, USA) was used for other statistical analyses. Statistical data were expressed as mean and standard deviation, while categorical data were expressed as frequency and percentage. Comparison of categorical data in the groups was done with Chi-square, the results were given as %n. Shapiro-Wilk tests were used to determine if the numerical data fit the normal distribution. While the data fitting the normal distribution were evaluated with the Student's t-test. Mann- Whitney U tests were used to compare the data differ from the normal distribution. p <0.05 was considered statistically significant. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06001996
Study type Observational
Source Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Contact
Status Completed
Phase
Start date October 3, 2023
Completion date January 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT02422355 - A Focused Registry on the Femoral Neck System (FNS) in Patients With Femoral Neck Fractures
Completed NCT02197065 - Pilot Study of Atorvastatin for Orthopedic Surgery Patients Phase 2
Recruiting NCT01934946 - Rehabilitation Care for Hip Fracture N/A
Terminated NCT01667913 - Reliability of 6-Minutes Walking Test in Hip Fracture Patients N/A
Completed NCT01714336 - Does Tranexamic Acid Reduce the Need for Blood Transfusions in Patients Undergoing Hip Fracture Surgery? Phase 4
Terminated NCT01535781 - Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced? N/A
Completed NCT01174589 - Training of Patients With Hip Fracture Phase 2
Active, not recruiting NCT02362971 - External Validity of a Randomized Trial in Patients With a Femoral Neck Fracture N/A
Completed NCT01738776 - Nutritional Risk Factors for Hip Fracture: a Case Control Study N/A
Completed NCT02591342 - Comparison of a Cemented, Polished Tapered Stem and an Anatomic Stem for Femoral Neck Fracture N/A
Completed NCT01382875 - The Comparison of Comprehensive Multi-disciplinary Program and Conventional Care Program on Fragility Fracture Elderly Phase 3
Suspended NCT00521716 - Safety and Efficacy of the WaisFix100i for Intracapsular Femoral Fracture Fixation N/A
Terminated NCT00128115 - Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032) Phase 2
Active, not recruiting NCT00345488 - Fast Track Admittance of Hip Fracture Patients Phase 4
Completed NCT02409082 - Alzheimers Disease and Neuromarkers in Patients With Acute Hip Fractures N/A
Recruiting NCT04626934 - Cognitive Intervention and Rehabilitation Outcomes in Hip Fracture Patients N/A
Recruiting NCT02635763 - Peripheral Nerve Blocks in Elderly Patients With Hip Fracture N/A
Completed NCT02190903 - A Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia N/A
Completed NCT00848913 - Strength Training After Hip Fracture Surgery N/A
Active, not recruiting NCT00859378 - Cemented vs Non-cemented Semiendoprosthesis in the Treatment of Proximal Femoral Fractures N/A